Scott Clunas

Dr. Scott Clunas is a Senior Research Fellow at the School of Natural and Computing Sciences, University of Aberdeen. His research bridges chemistry and neuroscience, focusing on the development of inhibitors targeting pathological protein aggregation in neurodegenerative diseases.

His primary research interests include Alzheimer's disease, tau protein aggregation, medicinal chemistry, and chiral ligand synthesis. His work combines molecular design with biological evaluation to develop novel therapeutics.

The recent publications highlight a shift from fundamental organic synthesis in the late 1990s and early 2000s toward translational neuroscience and drug discovery by 2015. The research spans neurodegenerative disease modeling, inhibitor development, and mechanistic biochemistry, demonstrating a trajectory from synthetic chemistry to biomedical application.

Dr. Clunas has contributed to significant patentable discoveries in tau-targeting compounds, indicating strong industry or therapeutic application potential. However, no formal scientific awards or fellowships are mentioned in the provided text.

He has collaborated extensively with researchers such as C. R. Harrington, J. M. D. Storey, C. M. Wischik, and S. K. Armstrong. While no students are explicitly listed, his role in multi-author, long-term research projects suggests potential mentorship or team leadership. No information is available about specific grants or funding sources.

There is no mention of affiliated laboratories or research teams in the provided content.